5-Star Biotech Stock Watch: Celldex Therapeutics | Benzinga

Tuesday saw the market drop to the tune of almost 120 Dow points and nearly 13 S&P points.
But market sell-offs aren’t always a bad thing. After all, a pullback can provide a more ideal entry on a desired stock.
Thanks to the market rally over the last few weeks, a lot of stocks had broken up through key resistances. So Tuesday’s […]